Uncertainty in economic evaluation of innovative therapies is often managed by a call for more ev
Yes, the Orphan Drug Regulation 141/2000 cam
Both patients and the public have to be regularly informed about what the use and procedures of H
From diagnosis to treatment and in terms of medicines manufactured, healthcare biotechnology is a
Some 20-30 million Europeans are affected by rare diseases.
The European biotech industry is calling for a robust and transparent framework in which HTA woul
Biotechnology aims to target the causes of diseases rather than just the symptoms.
Biotechnology provides powerful tools to develop diagnostics and treatments for orphan diseases.
Biotechnology medicines and therapies use proteins, enzymes, antibodies and other substances natu